A lectin affinity workflow targeting glycosite-specific, cancer-related carbohydrate structures in trypsin-digested human plasma.
about
An engineered high affinity Fbs1 carbohydrate binding protein for selective capture of N-glycans and N-glycopeptidesAnalysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2011-2012.N-glycoproteome analysis of the secretome of human metastatic hepatocellular carcinoma cell lines combining hydrazide chemistry, HILIC enrichment and mass spectrometrySimultaneous Enrichment of Plasma Soluble and Extracellular Vesicular Glycoproteins Using Prolonged Ultracentrifugation-Electrostatic Repulsion-hydrophilic Interaction Chromatography (PUC-ERLIC) Approach.Lectin chromatography/mass spectrometry discovery workflow identifies putative biomarkers of aggressive breast cancers.Highly selective SiO2-NH2@TiO2 hollow microspheres for simultaneous enrichment of phosphopeptides and glycopeptides.Serum Glycoprotein Biomarker Discovery and Qualification Pipeline Reveals Novel Diagnostic Biomarker Candidates for Esophageal Adenocarcinoma.Mass spectrometry-based analyses showing the effects of secretor and blood group status on salivary N-glycosylation.Multiplexed Targeted Mass Spectrometry-Based Assays for the Quantification of N-Linked Glycosite-Containing Peptides in SerumLiquid-phase-based separation systems for depletion, prefractionation and enrichment of proteins in biological fluids and matrices for in-depth proteomics analysis--an update covering the period 2008-2011Tor1 regulates protein solubility in Saccharomyces cerevisiae.Glycopeptide analysis, recent developments and applications.N- and O-glycosylation in the murine synaptosome.Glycoprotein profiles of human breast cells demonstrate a clear clustering of normal/benign versus malignant cell lines and basal versus luminal cell lines.Glycopeptide enrichment and separation for protein glycosylation analysis.Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers.Quantitative mass spectrometric analysis of glycoproteins combined with enrichment methods.Chemical Glycoproteomics.High-throughput analysis of N-glycans using AutoTip via glycoprotein immobilization.LC-MS/MS quantitation of esophagus disease blood serum glycoproteins by enrichment with hydrazide chemistry and lectin affinity chromatography.N-linked glycoproteome profiling of human serum using tandem enrichment and multiple fraction concatenation.Elucidation of N-glycosites within human plasma glycoproteins for cancer biomarker discovery.HILIC and ERLIC Enrichment of Glycopeptides Derived from Breast and Brain Cancer Cells.Human disease glycomics: technology advances enabling protein glycosylation analysis - part 1.Synthesis of bifunctional TiO2@SiO2-B(OH)2@Fe3O4@TiO2 sandwich-like nanosheets for sequential selective enrichment of phosphopeptides and glycopeptides for mass spectrometric analysis.Multi-Lectin Affinity Chromatography for Separation, Identification, and Quantitation of Intact Protein Glycoforms in Complex Biological Mixtures.Multi-lectin Affinity Chromatography and Quantitative Proteomic Analysis Reveal Differential Glycoform Levels between Prostate Cancer and Benign Prostatic Hyperplasia Sera.Enhanced N-glycosylation site exploitation of sialoglycopeptides by peptide IPG-IEF assisted TiO2 chromatography
P2860
Q33759186-ACE9E2A9-280A-4208-8952-839EEE5DB306Q34489424-1A25E396-8322-40EF-B06E-402C9359129CQ35064045-973BE9AF-DF32-4D9F-AD6D-7E48A6265900Q35692136-0BFC27BC-5B82-4370-96AF-B9E339B94AC2Q36058024-A74F5E19-F584-46C2-8587-0897288402D6Q36207408-2E05907F-2B3C-4689-B900-EDFE0C1C7874Q36263057-FE88BF4F-45AF-4CC2-91C6-E123E8B407A6Q36417069-0873422B-8CF2-4B34-9806-7B6C55D17717Q36451478-B74F82D8-A20D-4423-A04D-359C078A46C9Q36452318-A1FB72CE-197C-4C8C-9126-388DD89F62AEQ36465061-72E564FC-B498-4BE4-99A6-414D8047C9EFQ36742418-26C98B3C-43D7-4781-8FEE-5B03299CA7A4Q37388959-EAA1DA1E-490D-407F-8EA0-E52BC600BAE1Q37698291-64861218-35EA-4299-96D0-367C18D01523Q38045258-3B1CC511-278B-417E-BCC7-AE1C29671A89Q38194576-E099432D-9F46-4F6C-97DE-4A93054CAE8AQ38217009-4878CD3C-7124-47DC-8137-42D224A2D84DQ39037656-D7D2B00E-7011-4089-9794-2AD75C172C48Q41579640-400AA281-C2C8-498D-9A46-2A14CE144F2BQ42998397-C871EDCF-CE45-45C8-AA9D-6ADFFD1B8182Q45345975-9A4E5AA3-7330-4F08-B1D9-5555493D2813Q45964619-33F629FB-3CA2-4932-9AD6-6BF4A5C6CC2FQ47170200-BA3A6EC3-5D43-4709-9D6E-8BD4F4380D63Q47212798-48A6071D-4934-4C07-AD12-D8783FE10685Q50848486-5C6ABE9C-F4D0-45F0-916F-3BCD20925A09Q51141522-62032FB4-66EE-4F4E-989A-3870FAD225E1Q54949772-4E3AA00D-B23F-47EB-B623-9D245F722F01Q57149467-64EB4989-F307-4EAA-ABD8-832E6C04DA23
P2860
A lectin affinity workflow targeting glycosite-specific, cancer-related carbohydrate structures in trypsin-digested human plasma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A lectin affinity workflow tar ...... trypsin-digested human plasma.
@ast
A lectin affinity workflow tar ...... trypsin-digested human plasma.
@en
type
label
A lectin affinity workflow tar ...... trypsin-digested human plasma.
@ast
A lectin affinity workflow tar ...... trypsin-digested human plasma.
@en
prefLabel
A lectin affinity workflow tar ...... trypsin-digested human plasma.
@ast
A lectin affinity workflow tar ...... trypsin-digested human plasma.
@en
P2093
P2860
P356
P1476
A lectin affinity workflow tar ...... trypsin-digested human plasma.
@en
P2093
Bensheng Li
Birgit Schilling
Bradford W Gibson
Dylan J Sorensen
Eric Johansen
Fred E Regnier
H Ewa Witkowska
Haichuan Liu
Michael Lerch
Miles Braten
P2860
P356
10.1016/J.AB.2010.08.010
P407
P577
2010-08-10T00:00:00Z